Text Message (SMS) to Help Cancer Patients in Chemotherapy Treatment

Not Applicable

• Conditions: Cancer; Side Effect
• Interventions: Behavioral: Text message intervention

• Registration Number: NCT03087422
• Lead Sponsor: Samanta Winck Madruga

Brief Summary

This study evaluates the text message (SMS) with orientation to help the management of chemotherapy treatment.

Detailed Description

The investigators developed an app (called ChemotherApp) for Android that automatically sends text messages with homecare orientation to cancer patients in intervention group. The main features of this app are: to register information such as name, number of cellphone, gender, and chemotherapy schedule of the patient. Other feature is to register the orientation that will be sent to patients by text messages. Daily, the app send a registered orientation to each patient.

Study Timeline

• Study Start: 2016-08-01
• Status Verified: 2017-03
• Study First Submitted: 2017-03-03
• Study First Submitted QC: 2017-03-16
• Last Update Submitted: 2017-03-16
• Study First Posted: 2017-03-22
• Last Update Posted: 2017-03-22
• Primary Completion: 2017-09-01
• Study Completion: 2017-12-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Cancer patients who will start chemotherapy treatment in Hospital Escola of Federal University of Pelotas.

Exclusion Criteria

• Illiterate patients; Patients who do not have their own cell phone

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
intervention	Text message intervention	The patients in this group will receive daily a text message (SMS) with some orientation about Homecare as an attempt to minimize the side effects of chemotherapy. The text messages are based on oncology guidelines.The text messages contain information about water intake, emotional support, hygiene, immunity, nutrition, and physical activity. In addition, text messages about prevention and management of symptoms were also developed: nausea and vomiting, diarrhea, constipation, gas, changes in the skin and taste. Also, the patients allocated in this group will receive the standard care.

Primary Outcome Measures

Name	Time	Method
Change from Chemotherapy Side Effects - QLQ-C30 EORTC questionnaire	Up to 4 month	To measure the side effects, the QLQ-C30 EORTC questionnaire is going to be used. This questionnaire aims to identify if the patient had nausea and vomit, diarrhea, pain, fever, constipation, diarrhea, gas, among other symptoms. It will be investigated if patients who will receive the text message will have less side effects than patients who will not receive text messages. The questionnaire will be applied to each patient in the study at the beginning of the second,third and fourth cycles of chemotherapy.

Secondary Outcome Measures

Name	Time	Method
Change from Anxiety and Depression - HADS (Hospital Anxiety and Depression Scale) questionnaire	Up to 4 month	To measure anxiety and depression, the HADS (Hospital Anxiety and Depression Scale) questionnaire is going to be used. It will be investigated if patients who will receive the text message will have less score of depression and anxiety than patients who will not receive text messages. The HADS questionnaire is going to be applied to each patient on the first day of treatment and at the beginning of the fourth cycle of chemotherapy.

Trial Locations

Locations (1)

Federal University of Pelotas; 🇧🇷 Pelotas, RS, Brazil